glp-1 comparison Lilly orforglipron oral phase 3 weight loss trial GLP-1 vs Hormone Therapy: Which

Marketing materials saturated digital, print, and broadcast media with messages about life-changing weight loss while omitting meaningful risk disclosures about potential permanent digestive dysfunction

Mild nausea, diarrhea, constipation, and headaches are common but usually temporary as the body adjusts to the medication.

The GLP-3 peptide research and triple-agonist medications like retatrutide point to a future where multiple receptor targets are activated simultaneously

This is tied to Medicare coverage rules and how TRICARE coordinates benefits, not a standalone expansion or rollback of TRICARE policy

GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans

My name is Nevada Gray (@thepaleopharmacist) and I'm a 42-year-old pharmacist and registered nurse living in Boston